ACADIA Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. ACADIA Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 40% to $726,437,000. The net income raised on -$61,286,000 and profit margin reached -8%. Total operating expenses were $754,085,000.
Profit Margin
| 2014 | 120K | -92.47M | -77062.5% |
|---|---|---|---|
| 2015 | 61K | -164.44M | -269578.69% |
| 2016 | 17.33M | -271.39M | -1565.94% |
| 2017 | 124.90M | -289.40M | -231.71% |
| 2018 | 223.80M | -245.19M | -109.56% |
| 2019 | 339.07M | -235.25M | -69.38% |
| 2020 | 441.75M | -281.58M | -63.74% |
| 2021 | 484.14M | -167.87M | -34.67% |
| 2022 | 517.23M | -215.97M | -41.76% |
| 2023 | 726.43M | -61.28M | -8.44% |
ACAD Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 726.43M | 517.23M | 484.14M | 441.75M | 339.07M | 223.80M | 124.90M | 17.33M | 61K | 120K |
Cost of revenue | 45.73M | 10.16M | 19.14M | 20.55M | 19.59M | 18.33M | 13.06M | 4.40M | 76.36M | 60.60M |
Gross profit | 680.70M | 507.06M | 465.00M | 421.20M | 319.47M | 205.47M | 111.84M | 12.92M | -76.30M | -60.48M |
Operating exp. | ||||||||||
Research and development | 351.61M | 361.57M | 239.41M | 319.13M | 240.38M | 187.16M | 149.18M | 99.28M | 73.86M | 60.60M |
Selling and marketing | 9.4M | 5.5M | 41.8M | 51.1M | 38.3M | 0 | 15.6M | 0 | 0 | 0 |
Total operating expenses | 754.08M | 730.66M | 635.44M | 707.79M | 566.02M | 452.92M | 404.25M | 285.74M | 164.67M | 93.35M |
Operating income | -73.37M | -223.59M | -170.43M | -286.58M | -246.54M | -247.44M | -292.41M | -272.81M | -164.61M | -93.23M |
Other income (expenses), net | 22.34M | 10.15M | 2.92M | 5.61M | 12.16M | -1.84M | 4.12M | 2.76M | 499K | 755K |
Income before tax | -51.03M | -213.44M | -167.51M | -280.97M | -234.38M | -243.93M | -288.28M | -270.05M | -164.11M | -92.47M |
Income tax expense | 10.25M | 2.53M | 351K | 611K | 876K | 1.25M | 1.11M | 1.34M | 330K | -206K |
Net income | -61.28M | -215.97M | -167.87M | -281.58M | -235.25M | -245.19M | -289.40M | -271.39M | -164.44M | -92.47M |
Earnings per share | ||||||||||
Basic EPS | -0.37 | -1.34 | -1.05 | -1.79 | -1.6 | -1.94 | -2.36 | -2.34 | -1.63 | -0.95 |
Diluted EPS | -0.37 | -1.34 | -1.05 | -1.79 | -1.6 | -1.94 | -2.36 | -2.34 | -1.63 | -0.95 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |